Pharmacologic management of arrhythmias

Tex Heart Inst J. 2011;38(4):344-9.

Authors

Leila Ganjehei¹, Ali Massumi, Alireza Nazeri, Mehdi Razavi

Affiliation

¹ Department of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA.

PMID: 21841856
PMCID: PMC3147219

No abstract available

Publication types

Review

MeSH terms

Anti-Arrhythmia Agents / adverse effects
Anti-Arrhythmia Agents / therapeutic use*
Arrhythmias, Cardiac / drug therapy*
Arrhythmias, Cardiac / metabolism
Arrhythmias, Cardiac / physiopathology
Heart Conduction System / drug effects*
Heart Conduction System / metabolism
Heart Conduction System / physiopathology
Humans
Potassium Channel Blockers / pharmacology
Sodium Channel Blockers / therapeutic use
Treatment Outcome

Substances

Anti-Arrhythmia Agents
Potassium Channel Blockers
Sodium Channel Blockers